Browsing by Author "Jagust, William J."

Now showing items 1-3 of 3

    • A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers 

      Jack, Clifford R.; Bennett, David A.; Blennow, Kaj; Carrillo, Maria C.; Feldman, Howard H.; Frisoni, Giovanni B.; Hampel, Harald; Jagust, William J.; Johnson, Keith A.; Knopman, David S.; Petersen, Ronald C.; Scheltens, Philip; Sperling, Reisa A.; Dubois, Bruno (Lippincott Williams & Wilkins, 2016)
      Biomarkers have become an essential component of Alzheimer disease (AD) research and because of the pervasiveness of AD pathology in the elderly, the same biomarkers are used in cognitive aging research. A number of current ...

    • Aβ Imaging: Feasible, Pertinent, and Vital to Progress in Alzheimer’s Disease 

      Villemagne, Victor L.; Klunk, William E.; Mathis, Chester A.; Rowe, Christopher C.; Ikonomovic, Milos D.; Ishii, Kenji; Jack, Clifford R.; Jagust, William J.; Koeppe, Robert A.; Lowe, Val J.; Masters, Colin L.; Montine, Thomas J.; Morris, John C.; Nordberg, Agneta; Petersen, Ronald C.; Reiman, Eric M.; Van Laere, Koen; Drzezga, Alexander; Brooks, David J.; Hyman, Bradley Theodore; Johnson, Keith Alan; Selkoe, Dennis J.; Sperling, Reisa Anne; Weiner, Michael W. (Springer-Verlag, 2012)

    • The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI) 

      Risacher, Shannon L.; Kim, Sungeun; Shen, Li; Nho, Kwangsik; Foroud, Tatiana; Green, Robert C; Petersen, Ronald C.; Jack, Clifford R.; Aisen, Paul S.; Koeppe, Robert A.; Jagust, William J.; Shaw, Leslie M.; Trojanowski, John Q.; Weiner, Michael W.; Saykin, Andrew J. (Frontiers Media S.A., 2013)
      Objective: Our goal was to evaluate the association of APOE with amyloid deposition, cerebrospinal fluid levels (CSF) of Aβ, tau, and p-tau, brain atrophy, cognition and cognitive complaints in E-MCI patients and cognitively ...